BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $510,386 | -37.8% | 10,163 | -21.7% | 0.02% | -38.7% |
| Q2 2023 | $820,462 | +195.7% | 12,982 | +110.5% | 0.03% | +158.3% |
| Q1 2023 | $277,453 | -42.8% | 6,167 | -44.3% | 0.01% | -58.6% |
| Q4 2022 | $485,152 | -56.1% | 11,074 | -34.0% | 0.03% | -58.0% |
| Q3 2022 | $1,105,000 | +194.7% | 16,773 | +126.1% | 0.07% | +392.9% |
| Q2 2022 | $375,000 | +55.0% | 7,418 | +95.7% | 0.01% | +55.6% |
| Q1 2022 | $242,000 | -51.5% | 3,791 | -26.1% | 0.01% | -64.0% |
| Q1 2021 | $499,000 | +59.4% | 5,130 | +83.7% | 0.02% | +78.6% |
| Q4 2020 | $313,000 | +25.2% | 2,792 | +3.7% | 0.01% | +16.7% |
| Q3 2020 | $250,000 | -72.7% | 2,693 | -82.8% | 0.01% | -81.8% |
| Q1 2020 | $916,000 | +44.5% | 15,671 | +98.1% | 0.07% | +135.7% |
| Q4 2019 | $634,000 | – | 7,910 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 379,090 | $19,037,900 | 17.25% |
| DAFNA Capital Management LLC | 249,521 | $12,530,945 | 3.90% |
| Rock Springs Capital Management LP | 2,685,294 | $134,855,465 | 3.61% |
| Casdin Capital, LLC | 371,378 | $18,650,603 | 2.06% |
| Novo Holdings A/S | 525,000 | $26,365,500 | 1.95% |
| CHI Advisors LLC | 92,888 | $4,664,835 | 1.85% |
| SECTORAL ASSET MANAGEMENT INC | 165,890 | $8,330,996 | 1.62% |
| Avidity Partners Management LP | 751,600 | $37,745,352 | 1.52% |
| EMERALD ADVISERS, LLC | 607,037 | $30,485,393 | 1.48% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 464,321 | $23,318,201 | 1.41% |